Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4

Benzinga Newsdesk www.benzinga.com Negative 71.7%

Neg 71.7% Neu 0% Pos 0%

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.